Meeting on the Mesa 2021 | Utilizing single-cell multi-omics throughout the product pipeline

Yan Zhang, PhD, Mission Bio, San Francisco, CA, discusses how DNA and protein single-cell multi-omics can be applied throughout the development pipeline of advanced therapies. The Tapestri Platform can optimize the design of therapies by expediting the target validation process. The platform can additionally monitor therapeutic efficacy in various animal models in the preclinical stages, as well as humans in clinical trials. This interview took place at Meeting on the Mesa 2021.